Search results for “Progressive disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 116 patents, we discovered top 25 key players by total patent application. Novartis AG, Merck Patent GmbH, BioNTech SE are dominant in this area. They take 42.24% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 17
Merck Patent GmbH
Hessen, Germany
Patent: 17
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 15
Ojai Retinal Technology LLC
California, United States
Patent: 14
Cota, Inc.
New York, United States
Patent: 3
Green + Joint Stock Corp.
Bến Tre, Vietnam
Patent: 3
Innate Pharma SA
France
Patent: 2
Herantis Pharma Oyj
Finland
Patent: 2
Mayer & Co. Beschläge GmbH
Salzburg, Austria
Patent: 2
Splash Pharmaceuticals, Inc.
California, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Asylia Diagnostics BV
Delaware, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 79 patents applied in the last 5 years. We discover 15 most active companies in this area. The fast-growing BioNTech SE, TRON - Translationale Onkologie an der Universitätsmedizin der, Ojai Retinal Technology LLC take 40.51% of patent filing during this period.
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 15
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 10
Ojai Retinal Technology LLC
California, United States
Patent: 7
Nanjing University of Chinese Medicine
Jiangsu Sheng, China
Patent: 6
Univ of Pittsburgh
United States
Patent: 4
The Board of Regents of The University of Texas System
Texas, United States
Patent: 4
National Center of Neurology & Psychiatry
Tokyo-to, Japan
Patent: 3
Cota, Inc.
New York, United States
Patent: 3
Green + Joint Stock Corp.
Bến Tre, Vietnam
Patent: 3
Herantis Pharma Oyj
Finland
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 79 patents in last 5 years, we discover 12 new entrants. BioNTech SE, TRON - Translationale Onkologie an der Universitätsmedizin der, Nanjing University of Chinese Medicine are the most active new entrants in this area.
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 15
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 10
Nanjing University of Chinese Medicine
Jiangsu Sheng, China
Patent: 6
The Board of Regents of The University of Texas System
Texas, United States
Patent: 4
National Center of Neurology & Psychiatry
Tokyo-to, Japan
Patent: 3
Green + Joint Stock Corp.
Bến Tre, Vietnam
Patent: 3
Cota, Inc.
New York, United States
Patent: 3
Herantis Pharma Oyj
Finland
Patent: 2
Splash Pharmaceuticals, Inc.
California, United States
Patent: 2
Debiotech SA
Vaud, Switzerland
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 35 patents, we discovered top 5 universities and scientific research institutions by total patent application. Nanjing University of Chinese Medicine, Fudan University, Nanjing University are dominant in this area. They take 57.14% of the total patent filing.
Nanjing University of Chinese Medicine
Jiangsu Sheng, China
Patent: 6
Fudan University
Shanghai Shi, China
Patent: 1
Nanjing University
Jiangsu Sheng, China
Patent: 1
Heilongjiang University of Chinese Medicine
Heilongjiang Sheng, China
Patent: 1
Shanxi University
Shanxi Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: